Send Your Enquiry
Prof. Dr. Eckhart Weidmann
Hematologist
Nordwest Hospital, Frankfurt · Frankfurt
38+ years of experience
About Prof. Dr. Elke Jaeger
- Prof. Dr. Elke Jaeger is a Hematologist-Oncologist in Germany with experience of over 35+ years.
- She is the Chair of Interdisciplinary Oncology at Goethe University Frankfurt and is a member of the Academy of Cancer Immunology, USA, and an adjunct Professor at Roswell Park Cancer Center, USA.
- She received her medical education from the universities of Mainz, Würzburg, Cologne from 1979 to 1985, and later did her Ph.D. in internal medicine from the Bavarian Julius Maximilian University, Würzburg in 1986.
- She has run numerous Phase I clinical trials in the field of experimental oncology medicines and managed a variety of clinical Phase II/III trials for pharmaceutical treatments of various malignant diseases.
- She also has trained students in the practical year at the Johann Wolfgang Goethe University, Frankfurt.
- Her areas of interest are the treatment of leukemia and lymphoma, Radiochemotherapy, stem cell transplant (autologous, allogenic & umbilical cord blood transplant), Antibody Therapy, Immunotherapy, anemia, etc.
- Dr. Jaeger has presented many papers at diverse conferences held nationally and internationally.
Location
Graduation, Universities of Mainz, Würzburg, Cologne(1979)- Post Graduation, Bavarian Julius Maximilian University, Würzburg(1986)
- Associate Consultant, Department of Pathology at Johannes Gutenberg University, Mainz
Papers Published
- Knuth, A., Bernhard, H., Jäger, E., Wolfel, T., Karbach, J., Jaggle, C., Strittmatter, W., Meyer zum Buschenfelde, K.H. Induction of tumour cell lysis by a bispecific antibody recognizing epidermal growth factor receptor (EGFR) and CD3. Eur J Cancer 30A:1103-7, 1994.
+ Read More- Show Less
- Bergmann, L., Karakas, T., Lautenschlager, G., Jäger, E., Knuth, A., Mitrou, P.S., Hoelzer, D. Vincristine, doxorubicin, cyclophosphamide, prednisone, and etoposide (VACPE) in high-grade non-Hodgkin's lymphoma--a multicenter phase II study. Ann Oncol 6:1019-24, 1995.
- Bernhard, H., Jäger, E., Bernhard, G., Heike, M., Klein, O., Riemann, J.F., Meyer zum Buschenfelde, K.H., Dippold, W., Knuth, A. Treatment of advanced pancreatic cancer with 5-fluorouracil, folinic acid and interferon alpha-2A: results of a phase II trial. Br J Cancer 71:102-5, 1995.
- Jäger, E., Bernhard, H., Klein, O., Wachter, B., Theiss, F., Dippold, W., Meyer zum Buschenfelde, K.H., Knuth, A. Combination 5-fluorouracil (FU), folinic acid (FA), and alpha-interferon 2B in advanced gastric cancer: results of a phase II trial. Ann Oncol 6:153-6, 1995.
- Jäger, E., Klein, O., Wächter, B., Muller, B., Braun, U., Knuth, A. Second-line treatment with high-dose 5- fluorouracil and folinic acid in advanced colorectal cancer refractory to standard-dose 5-fluorouracil treatment. Oncology 52:470-3, 1995.
- Jäger, E., Klein, O., Wächter, B., Muller, B., Braun, U., Knuth, A. High dose 5-fluorouracil (5-FU) and folinic acid in advanced colorectal cancer resistant to standard dose 5-FU treatment: results of a phase II study. Eur J Cancer 31A:1717, 1995.
Send Your Enquiry
Fill in your details and our medical experts will contact you within 24 hours.
Want to consult the doctor?
Don't Ignore Your Health!
Other Top Hematologist In Frankfurt
ChatFAQ's About Prof. Dr. Elke Jaeger
Where does Prof. Dr. Elke Jaeger practice?
Prof. Dr. Elke Jaeger practices at Nordwest Hospital, Frankfurt
What is the specialty of Prof. Dr. Elke Jaeger?
Prof. Dr. Elke Jaeger specialty is Hematologist
What is the experience of Prof. Dr. Elke Jaeger?
Prof. Dr. Elke Jaeger is Hematologist with 39 years of experience.
Chat